Temozolomide and cisplatin versus temozolomide in patients with advanced melanoma: a randomized phase II study of the Hellenic Cooperative Oncology Group

Autor: Bafaloukos, D., Tsoutsos, D., Kalofonos, H., Chalkidou, S., Panagiotou, P., Linardou, E., Briassoulis, E., Efstathiou, E., Polyzos, A., Fountzilas, G., Christodoulou, C., Kouroussis, C., Iconomou, T., Gogas, H. ^*

Publikováno v: In Annals of Oncology June 2005 16(6):950-957

Population Pharmacokinetics and Pharmacodynamics of Paclitaxel and Carboplatin in Ovarian Cancer Patients: A Study by the European Organization for Research and Treatment of Cancer-Pharmacology and Molecular Mechanisms Group and New Drug Development Group

Autor: Joerger, M., Huitema, A. D. R., Richel, D. J., Dittrich, C., Pavlidis, Nicholas, Briassoulis, E. Ch, Vermorken, J. B., Strocchi, E., Martoni, A., Sorio, R., Sleeboom, H. P., Izquierdo, M. A., Jodrell, D. I., Calvert, H., Boddy, A. V., Hollema, H., Féty, R., Vijgh, W. J. F. Van Der, Hempel, G., Chatelut, E., Karlsson, M., Wilkins, J., Tranchand, B., Schrijvers, A. H. G. J., Twelves, C., Beijnen, J. H., Schellens, J. H. M.

Publikováno v: Clinical Cancer Research, 13(21), 6410-6418. AMER ASSOC CANCER RESEARCH
Clinical cancer research, 13(21), 6410-6418. American Association for Cancer Research Inc.
Clinical Cancer Research
Clinical cancer research

Purpose: Paclitaxel and carboplatin are frequently used in advanced ovarian cancer following cytoreductive surgery. Threshold models have been used to predict paclitaxel pharmacokinetic-pharmacodynamics, whereas the time above paclitaxel plasma conce

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f35d45e907084e44cb16cab0bcb5b9df
https://doi.org/10.1158/1078-0432.ccr-07-0064

Clinicopathologic study of vascular endothelial growth factor, thrombospondin-1, and microvessel density assessed by CD34 in patients with stage III ovarian carcinoma

Autor: Karavasilis, V., Malamou-Mitsi, Vassiliki D., Briassoulis, E. Ch, Tsanou, E., Kitsou, E., Pavlidis, Nicholas

Publikováno v: International Journal of Gynecological Cancer

The aim of the study was to investigate angiogenesis in patients with advanced-stage ovarian carcinoma. We used paraffin-embedded tumor tissues from 33 patients diagnosed with FIGO III ovarian cancer who had optimal surgery and received platinum-base

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca76e441beb193da1df7ad73556c7226
https://doi.org/10.1136/ijgc-00009577-200602001-00039

Phase I Trial of Intravenous Cisplatin-Topotecan Chemotherapy for Three Consecutive Days in Patients with Advanced Solid Tumors: Parallel Topotecan Escalation in Two Fixed Platinum Dosing Schemes

Autor: Pentheroudakis, George, Briassoulis, E. Ch, Karavasilis, V., Mauri, D., Tzamakou, E., Rammou, D., Pavlidis, Nicholas

Publikováno v: Chemotherapy

Purpose: We performed a phase I study of two fixed dosing schemes of cisplatin, a DNA cross-linker, with intravenous escalating topotecan, a DNA-topoisomerase I inhibitor. Experimental Design: 40 patients with advanced solid tumors received intraveno

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28b8ddeed875ed278e4d4bad707d9eee
https://doi.org/10.1159/000085624

Dose-Dense Sequential Chemotherapy With Epirubicin and Paclitaxel Versus the Combination, as First-Line Chemotherapy, in Advanced Breast Cancer: A Randomized Study Conducted by the Hellenic Cooperative Oncology Group

Autor: Fountzilas, George, Papadimitriou, C., Dafni, U., Bafaloukos, Dimitrios, Skarlos, Dimosthenis V., Moulopoulos, L. A., Razi, E. D., Kalofonos, H. P., Aravantinos, Gerasimos, Briassoulis, E. Ch, Papakostas, P., Abela, K., Gogas, H., Kosmidis, Paraskevas A., Pavlidis, Nicholas, Dimopoulos, M. A.

Publikováno v: Scopus-Elsevier
Journal of Clinical Oncology

PURPOSE: To compare the efficacy of two different schedules of epirubicin and paclitaxel, as first-line chemotherapy, in patients with advanced breast cancer (ABC). PATIENTS AND METHODS: From October 1997 until May 1999, 183 eligible patients with AB

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e27f3feebe5e6650f759a97baa2237c2
https://doi.org/10.1200/jco.2001.19.8.2232